Zimmer Biomet Holdings, Inc. (ZBH) has a MoatMap StockRank of 89/100 based on Quality (57/100), Value (55/100), and Momentum (62/100) factor scores. The current signal is STRONG BUY. Slow-growing orthopedic device maker with high debt and no alignment with our high-conviction 18-month macro themes.
Zimmer Biomet Holdings, Inc. is a global leader in musculoskeletal healthcare, specializing in the design, manufacture, and marketing of orthopedic reconstructive products, spine and dental solutions, and related surgical technologies. The company maintains a strong competitive position through its expansive product portfolio, deep relationships with surgeons and hospitals, and continuous R&D investment in innovative surgical solutions. Zimmer Biomet is a dominant force in the global orthopedic implant market.
| Price | $87.38 |
| Market Cap | $16.0B |
| P/E (TTM) | 22.46 |
| P/E (Forward) | 9.63 |
| Price/Book | 1.32 |
| Return on Equity | 6.1% |
| Return on Invested Capital | 5.5% |
| Debt/Equity | 59.83 |
| Gross Margin | 70.2% |
| Operating Margin | 19.7% |
| Revenue Growth | 9.3% |
| Dividend Yield | 1.1% |
| Free Cash Flow | $1.0B |
Zimmer Biomet Holdings, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).